References

1. Mahgoub ES, Murray IG. Mycetoma. London: William Heinemann Medical, 1973.

2. Mariat F. Sur la distribution geographique et la repartition des agents des mycetomes. Bull Soc Path Exot 1963;56:35-45.

3. Hay RJ, Mackenzie DWR. Mycetoma (Madura foot) in the United Kingdom - a survey of 44 cases. Clin Exp Dermatol 1983;8:553-62.

4. Hay RJ, Mahgoub ES, Leon G et al. Mycetoma. J Med Vet Mycol 1992;30(Suppl. 1):41-9.

5. Boiron P, Locci R, Goodfellow M et al Nocardia, nocardiosis and mycetoma. Med Mycol 1998;36(Suppl. 1):26-37.

6. Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol 1995;6:47-71.

7. Ramam M, Garg T, D'Souza P et al. A two-step schedule for the treatment of actinomycotic mycetomas. Acta Derm Venereol 2000;80:378-80.

8. Gugnani HC, Ezeanolue BC, Khalil M et al. Fluconazole in the therapy of tropical deep mycoses. Mycoses 1995;38:485-8.

9. Paugam A, Tourte-Schaefer C, Keita A et al. Clinical cure of fungal madura foot with oral itraconazole. Cutis 1997;60:191-3.

10. Lee MW, Kim JC, Choi JS, Kim KH, Greer DL. Mycetoma caused by Acremonium falciforme: successful treatment with itraconazole. J Am Acad Dermatol 1995;32:897-900.

11. Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999;141(Suppl. 56):36-40.

12. Subrahmanyam M. Intra-arterial chemotherapy for mycetoma of the foot. Br J Surg 1995;82:643.

13. Ghosh A, Chakrabarti A, Sharma VK, Singh K, Singh A. Sporotrichosis in Himachal Pradesh (north India). Trans R Soc Trop Med Hyg 1999;93:41-5.

14. Conias S, Wilson P. Epidemic cutaneous sporotrichosis:report of 16 cases in Queensland due to mouldy hay. Aust J Dermatol 1998;39:34-7.

15. Pappas PG, Tellez I, Deep AE et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect. Dis 2000;30:65-70.

16. Tobin EH, Jih WW. Sporotrichoid lymphocutaneous infections: etiology, diagnosis and therapy. Am Fam Phys 2001;63:326-32.

17. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis 1995;21:981-5.

18. Noguchi H, Hiruma M, Kawada A. Case report. Sporotrichosis successfully treated with itraconazole in Japan. Mycoses 1999;42:571-6.

19. Karakayali G, Lenk N, Alli N, Gungor E, Artuz F. Itraconazole therapy in lymphocutaneous sporotrichosis: a case report and review of the literature. Cutis 1998;61:106-7.

20. Kauffman CA, Pappas PG, McKinsey DS et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996;22:46-50.

21. Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J 1996;15:352-4.

22. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis 2000;30:684-7.

23. Bargman H. Successful treatment of cutaneous sporotrichosis with liquid nitrogen:report of three cases. Int J Dermatol 1995;38:285-7.

24. Minotto R, Bernardi CD, Mallmann LF et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001;44:585-92.

25. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001;44:1-7.

26. Esterre P, Inzan CK, Ramarcel ER et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996:134(Suppl. 46):33-6.

27. Tanuma H, Hiramatsu M, Mukai H et al. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan. Mycoses 2000:43:79-83.

28. Guerriero C, De Simone C, Tulli A. A case of chromoblastomycosis due to Phialophora verrucosa responding to treatment with fluconazole. Eur J Dermatol 1998;8:167-8.

29. Kombila M, Gomez de Diaz M, Richard-Lenoble D et al. Chromoblastomycosis in Gabon. Study of 64 cases. Sante 1995;5:235-44.

30. Kullavanijaya P, Rojanavanich V. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol 1995;34:804-7.

31. Hiruma M, Kawada A, Yoshida M, Kouya M. Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature. Mycopathologia 1993;122:107-14.

32. Kumarasinghe SP, Kumarasinghe MP. Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol 2000;10:220-2.

33. Poirriez J, Breuillard F, Francois N et al. A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg 2000:63:61-3.

34. Bonifaz A, Martinez-Soto E, Carrasco-Gerrard E, Peniche J. Treatment of chromoblastomycosis with itraconazole, cryosurgery and a combination of both. Int J Dermatol 1997:36:542-7.

35. Patel P, Ramanathan J, Kayser M, Baran J Jr. Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. J Am Acad Dermatol 2000:43:344-5.

36. Noble RC, Fajardo LF. Primary cutaneous cryptococcosis: review and morphologic study. Am J Clin Pathol 1972:57:13-22.

37. Antony SA, Antony SJ. Primary cutaneous cryptococcus in nonimmunocompromised patients. Cutis 1995:56:96-8.

38. Hamann ID, Gillespie RJ, Ferguson JK. Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent host. Aust J Dermatol 1997;38:29-32.

39. Sanchez P, Bosch RJ, de Galvez MV et al. Cutaneous cryptococcosis in two patients with acquired immunodeficiency syndrome. Int J STD AIDS 2000;11:477-80.

40. Coker LR, Swain R, Morris R, McCall CO. Disseminated cryptococcosis presenting as pseudofolliculitis in an AIDS patient. Cutis 2000;66:207-10.

41. Naka W, Masuda M, Konohana A et al. Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin Exp Dermatol 1995;20:221-5.

42. Glassman SJ, Hale MJ. Cutaneous cryptococcosis and Kaposi's sarcoma occurring in the same lesions in a patient with the acquired immunodeficiency syndrome. Clin Exp Dermatol 1995;20:480-6.

Was this article helpful?

0 0
Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook


Post a comment